Fig. 6: C20 and αCTLA-4 increased neoantigen-specific CD8 and switched B cells.
From: Neoantigen cancer vaccine augments anti-CTLA-4 efficacy

On day twenty, nine mice per group were sacrificed and tumors and splenocytes were analyzed by FC using the gating strategy depicted in Supplementary Fig. 2. a Frequency of E2f8 neoantigen-specific response was measured using the specific dextramer (Dx+) gated on CD45+CD3+ CD8+ in live cells. b Treg population (CD25+Foxp3+) were gated on CD45+CD3+CD4+ in live cells and expressed as ratio with DX+ cells (c). d Switched B cells were identified as CD19+IgG+ cells and gated on CD45+CD3+ in live cells. Nine animals per group were utilized and each symbol represents an individual sample. Significance was determined using Mann–Whitney test *p < 0.05 **p < 0.01 ***p < 0.001 ****p < 0.0001.